Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alvin Schmaier, MD
Case Western Reserve University
Principal Investigator - Ann Zimrin, MD
University of Maryland
Principal Investigator - Bruce Sachais, MD, PhD
University of Pennsylvania
Principal Investigator - Cindy Leissinger, MD
Tulane University
Principal Investigator - David Kuter, MD
Massachusetts General Hospital
Principal Investigator - Eliot Williams, MD
University of Wisconsin, Madison
Principal Investigator - Ellis Neufeld, MD
Boston Children's Hospital
Principal Investigator - James Bussel, MD
Weill Medical College, Cornell University
Principal Investigator - James George, MD
The University of Oklahoma
Principal Investigator - Jodi Segal, MD
Johns Hopkins University
Principal Investigator - Joseph Kiss, MD
University of Pittsburgh
Principal Investigator - Judith Lin, MD
Brigham and Women's Hospital
Principal Investigator - Michele Lambert, MD
Children's Hospital of Philadelphia
Principal Investigator - Nigel Key, MD
University of North Carolina, Chapel Hill
Principal Investigator - Susan F Assmann, PhD
Carelon Research
Principal Investigator - Terry Gernsheimer, MD
University of Washington
Principal Investigator - Thomas Ortel, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tulane University
New Orleans, Louisiana, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Maryland
Baltimore, Maryland, United States
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Weill Medical College, Cornell University
New York, New York, United States
- University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- the University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Presbyterian and Shadyside Hospital
Pittsburgh, Pennsylvania, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Gundersen Clinic
La Crosse, Wisconsin, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 Mar 2013
- Completion
- 31 Mar 2013
- Last update posted
- 14 Feb 2014
- Registered enrollment
- 8
- Registry id
- NCT00991939
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.